| Up
2005P-0076:
OXYCONTIN AND PALADONE REMOVAL FROM MARKET AND LABEL CHANGES LIMITING
INDICATIONS TO SEVERE CHRONIC PAIN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 02/17/2005
|
| 02/17/2005
|
| Individual Consumer
|
| Kirk Van Rooyan and
Barbara Van Rooyan
|
|
|
|
|
|
|
| TOC
|
|
|
|
|
| Signature:
|
| Kirk Van Rooyan and
Barbara Van Ro
|
|
|
|
|
| ACK1
|
| 02/18/2005
|
| 02/18/2005
|
| Federal
Government
|
| HFA-305
to Mr. Kirk Van Rooyan and Barbara Van Rooyan
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
| |
|
|
|
| SUP1
|
| 03/31/2005
|
| 03/31/2005
|
| Individual Consumer
|
| B Van Rooyan
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Barbara Van Rooyan
|
|
|
|
|
| C1
|
| 05/05/2005
|
| 05/04/2005
|
| Drug Industry
|
| Purdue Pharma LP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Richard S Morey
| |
|
|
|
| CR1
|
| 05/13/2005
|
| 05/11/2005
|
| Drug Industry
|
| Purdue Pharma L.P.
(Purdue)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Richard S. Morey
| |
Top
| Up
Page last updated
May 23, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
